TLR4 and neoplasm: Tian et al. found that the use of PCP led to a significant reduction in tumor volume and an increase in organ immunoreactivity indexes, and it exerted exogenous and internal immunomodulatory effects by activating the TLR4/TRAF6/NF-κB signaling pathway [57].